Wednesday 20th September 2017 |
Text too small? |
Orion Health is narrowing the number of options on the table as it works through a strategic review, which shook out potential investors in the business.
The healthcare software developer raised $32 million through a rights issue earlier this year to put it on a healthier footing as it chases a return to profit in the current financial year after a challenging 2017 forced restructuring. In May, a strategic review to search for sources of additional capital, including minority investments in the company, was given a broader mandate to bolster the long-term capital structure of Orion, and chairman Andrew Ferrier told shareholders at today's annual meeting in Auckland that the review is still going.
"The business has a number of options which it is currently in the process of narrowing down into a desirable outcome," Ferrier said in speech notes published on the NZX. "Further updates will be provided to shareholders at the appropriate time."
Orion affirmed its outlook for annual revenue of between $200 million to $220 million for the year ending March 31, 2018, and Ferrier said it's on track to be profitable in the second half.
However, restructuring costs and "the variability of contracting in the business" have a cloudier first-half performance, which is expected to post an operating loss of $20 million-to-$25 million.
An operational review of the business in April cut 76 jobs at Orion, which employs about 1,200 people worldwide, saving an annual $10 million. Presentation slides accompanying chief executive Ian McCrae's address show the company will retain a focus on cost and is currently ahead of target.
The shares last traded at $1.15, and have slumped 40 percent so far this year.
(BusinessDesk)
No comments yet
MPG - Metroglass clarifies media statements by Crescent Capital
VTL - Takeovers Panel orders Empire to reimburse Vital's expenses
March 14th Morning Report
SKT - Sky secures iconic sports rights
RYM - Ryman completes Retail Entitlement Offer
TEM - Transaction in Own Shares
FPH launches F&P Nova™ Nasal mask in NZ and AU
Fonterra announces changes to management team
March 12th Morning Report
WHS FY25 Interim Results teleconference details